Edoxaban Tosylate Related Compounds & Impurities

Edoxaban Tosylate is the tosylate salt of the direct factor Xa inhibitor edoxaban, used for stroke prevention in non-valvular atrial fibrillation and VTE treatment.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Edoxaban Tosylate reference standards, pharmacopeial and non-pharmacopeial Edoxaban Tosylate impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Edoxaban Tosylate-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Edoxaban Tosylate (RSS)-Isomer Methyl Benzene Sulfonate Salt
Edoxaban Impurity 100
Edoxaban Impurity 65
Edoxaban Chloro Impurity
Edoxaban Impurity 67
Edoxaban Impurity 130